-
Charlie's Holdings names Henry Sicignano CEO; COO Ryan Stump transitions to board role
Ryan Stump resigns as COO effective Sept 4, 2026, remains on board and will lead strategic partnerships.
-
Charlie's Holdings raises $710K via private placement of 3.55M shares at $0.20/share
Sold 3,550,000 shares of common stock at $0.20 per share to accredited investors.
-
Charlie's Holdings sells PACHA synthetic vape assets to R.J. Reynolds for $5M + up to $4.2M contingent
Asset sale includes twelve PACHA synthetic product SKUs and related PMTA filings to R.J. Reynolds Vapor Company.
-
Charlie's Holdings raises $550k via 6.875M share private placement at $0.08/sh
Sold 6,875,000 common shares at $0.08 each to accredited investors, gross proceeds ~$550k.
-
Charlie's Holdings raises ~$1.63M via sale of 20.4M shares at $0.08; discloses going concern doubt
Sold 20,375,000 shares of common stock at $0.08 per share, gross proceeds ~$1.63 million.
-
Charlie's Holdings auditor Mazars resigns after Q1 2024 filing; going concern noted
Mazars resigned April 17, 2024, effective after the Q1 2024 Form 10-Q filing.
-
Charlie's Holdings appoints Mazars USA as new auditor for FY2023
Audit Committee appointed Mazars USA LLP as independent registered public accounting firm for fiscal year ending Dec 31, 2023.
-
Charlie's Holdings dismisses Baker Tilly auditor; going concern note; new COO Stump
Audit committee dismissed Baker Tilly as independent auditor on June 19, 2023; Baker's 2021 and 2022 reports included going concern emphasis.
-
Charlie's Holdings appoints PMTA expert Dr. Edward Carmines to board; grants restricted stock to officers
Appointed Dr. Edward Carmines, Ph.D., to Board effective March 2, 2022; he is a PMTA/MRTP expert who secured FDA marketing order for 22nd Century Group.
-
Charlie's Holdings CEO Brandon Stump resigns; board transitions to independent majority for exchange uplist
CEO Brandon Stump resigns effective Nov 3, 2021; remains largest shareholder.